Published Date: 17 Feb 2023
BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...
Read Full NewsA yearly report from the American Association for Cancer Research lauds recent breakthroughs but warns on threatened federal funding changes.
A meta-analysis assesses the effect of nurse-led telenursing on the quality of life in women with breast cancer.
The 50-month follow-up of the ECHO trial underscores greater benefits with concurrent vs sequential addition of acalabrutinib to bendamustine and rituximab.
1.
Mouse study finds tirzepatide slowed obesity-associated breast cancer growth
2.
EBCC: European Breast Cancer Conference
3.
Germline Variants Predict Lobular Breast Cancer Recurrence
4.
A Win for Molecularly Guided Therapy for Cancer of Unknown Primary
5.
Joe Biden has prostate cancer with bone spread. An oncologist explains what you need to know
1.
Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification
2.
Drug Safety Strategies for Advanced Cellular Blood Product Administration
3.
Quality of Life Through Functional Reintegration After Personalized Cancer Recovery Pathways
4.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
5.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
Cancer Care: From Awareness to Recovery
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation